Venkataramana Kandi

4.1k total citations · 1 hit paper
187 papers, 2.3k citations indexed

About

Venkataramana Kandi is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Venkataramana Kandi has authored 187 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Infectious Diseases, 43 papers in Epidemiology and 33 papers in Molecular Biology. Recurrent topics in Venkataramana Kandi's work include SARS-CoV-2 and COVID-19 Research (21 papers), COVID-19 Clinical Research Studies (16 papers) and Antibiotic Resistance in Bacteria (10 papers). Venkataramana Kandi is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (21 papers), COVID-19 Clinical Research Studies (16 papers) and Antibiotic Resistance in Bacteria (10 papers). Venkataramana Kandi collaborates with scholars based in India, Saudi Arabia and Pakistan. Venkataramana Kandi's co-authors include Mahendra Pal, Sabitha Vadakedath, Ranjan K. Mohapatra, Adnan Bashir Bhatti, Ashish K. Sarangi, Muhammad Usman, Kuldeep Dhama, Snehasish Mishra, Tarun Kumar Suvvari and Debadutta Das and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Microbiology and RSC Advances.

In The Last Decade

Venkataramana Kandi

168 papers receiving 2.2k citations

Hit Papers

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV... 2020 2026 2022 2024 2020 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update
    2020 553 citations Mahendra Pal, Venkataramana Kandi et al. Cureus profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Venkataramana Kandi India 21 846 492 292 204 152 187 2.3k
Rakesh Sehgal India 26 665 0.8× 499 1.0× 266 0.9× 576 2.8× 161 1.1× 187 2.7k
Shailesh Kumar Patel India 23 702 0.8× 324 0.7× 142 0.5× 118 0.6× 218 1.4× 70 1.8k
Mohsen Heidary Iran 25 746 0.9× 599 1.2× 425 1.5× 92 0.5× 139 0.9× 87 2.0k
Joerg Steinmann Germany 30 1.4k 1.7× 588 1.2× 1.1k 3.6× 212 1.0× 119 0.8× 138 3.1k
Rajesh Pandey India 35 893 1.1× 1.3k 2.6× 631 2.2× 190 0.9× 236 1.6× 215 4.3k
Hossam M. Ashour United States 30 799 0.9× 799 1.6× 376 1.3× 322 1.6× 617 4.1× 65 3.3k
Siddharth Sridhar Hong Kong 31 2.3k 2.7× 373 0.8× 701 2.4× 317 1.6× 77 0.5× 112 4.3k
Leon Caly Australia 15 1.8k 2.1× 493 1.0× 402 1.4× 200 1.0× 23 0.2× 31 2.6k
Liping Wang China 32 1.2k 1.4× 442 0.9× 263 0.9× 885 4.3× 148 1.0× 147 2.9k
Amit Kumar Verma India 29 473 0.6× 441 0.9× 377 1.3× 235 1.2× 324 2.1× 165 2.9k

Countries citing papers authored by Venkataramana Kandi

Since Specialization
Citations

This map shows the geographic impact of Venkataramana Kandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Venkataramana Kandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Venkataramana Kandi more than expected).

Fields of papers citing papers by Venkataramana Kandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Venkataramana Kandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Venkataramana Kandi. The network helps show where Venkataramana Kandi may publish in the future.

Co-authorship network of co-authors of Venkataramana Kandi

This figure shows the co-authorship network connecting the top 25 collaborators of Venkataramana Kandi. A scholar is included among the top collaborators of Venkataramana Kandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Venkataramana Kandi. Venkataramana Kandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suvvari, Tarun Kumar & Venkataramana Kandi. (2024). Artificial intelligence enhanced infectious disease surveillance - A call for global collaboration. New Microbes and New Infections. 62. 101494–101494. 3 indexed citations
2.
3.
Suvvari, Tarun Kumar, et al.. (2023). Emergence of XBB.1.16—a new recombinant COVID-19 variant driving the surge of COVID-19 cases in India. SHILAP Revista de lepidopterología. 35(1). 1 indexed citations
4.
Kandi, Venkataramana, et al.. (2023). Exploring the Correlation Between Influenza A Virus (H3N2) Infections and Neurological Manifestations: A Scoping Review. Cureus. 15(3). e36936–e36936. 4 indexed citations
5.
Kandi, Venkataramana, et al.. (2023). Clinical Trials: The Role of Regulatory Agencies, Pharmacovigilance Laws, Guidelines, Risk Management, Patenting, and Publicizing Results. SHILAP Revista de lepidopterología. 6(1). 93–109. 2 indexed citations
6.
Mohapatra, Ranjan K., Snehasish Mishra, Venkataramana Kandi, et al.. (2022). Emerging monkeypox cases amid the ongoing COVID-19 pandemic in the Indian subcontinent: A probable healthcare challenge for South East Asia. Frontiers in Public Health. 10. 1066425–1066425. 9 indexed citations
7.
Mohapatra, Ranjan K., Nahed A. El‐Shall, Ruchi Tiwari, et al.. (2022). Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update. Human Vaccines & Immunotherapeutics. 18(5). 2065824–2065824. 20 indexed citations
8.
Kandi, Venkataramana, et al.. (2020). Animals and Food of Animal Origin as a Potential Source of Salmonellosis: A Review of the Epidemiology, Laboratory Diagnosis, Economic Impact and Public Health Significance. American journal of microbiological research. 8(2). 48–56. 5 indexed citations
9.
Kandi, Venkataramana, et al.. (2019). Enterobius Vermicularis: Does it Invade Central Nervous System?. 7(1). 8–12. 2 indexed citations
10.
11.
12.
Pal, Mahendra, et al.. (2017). A Review of Biotechnological Applications in Food Processing of Animal Origin. American journal of food science and technology. 5(4). 143–148. 1 indexed citations
13.
Kandi, Venkataramana & Adnan Bashir Bhatti. (2016). Advantages of Alternate Biomarkers in the Management of Human Immunodeficiency Virus with Highly Active Antiretroviral Therapy. 4(2). 32–34. 1 indexed citations
14.
Kandi, Venkataramana. (2016). Journal Publications, Indexing and Academic Excellence: Have We Chosen the Right Path. 4(3). 52–55. 1 indexed citations
15.
Kandi, Venkataramana, et al.. (2015). Determination of Antimicrobial Resistance Pattern and Production of Extended-Spectrum Β-Lactamases amongst Escherichia coli and Klebsiella pneumoniae from Clinical Isolates. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Deorukhkar, Sachin, et al.. (2014). Coagulase Activity of Candida Spp Isolated from HIV Seropositive Patients Using Different Animal Plasma. American journal of microbiological research. 2(2). 57–59. 4 indexed citations
17.
Kandi, Venkataramana. (2014). Dengue Viral Infection: Focus on Epidemiology, Laboratory Diagnosis, Management and Control Measures. 2(5). 249–252. 2 indexed citations
18.
19.
Kandi, Venkataramana, et al.. (2012). Prevalence and Evaluation of Toxin Genes among Uropathogenic Escherichia coli Clinical Isolates by Duplex PCR. 1(1). 17–22. 12 indexed citations
20.
Kandi, Venkataramana, et al.. (2010). Dammarane and ceanothane triterpenes from Zizyphus xylopyra.. International Journal of Chemical Sciences. 8(2). 1231–1239. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rakesh Sehgal Breakdown of academic impact, for papers by Shailesh Kumar Patel Breakdown of academic impact, for papers by Mohsen Heidary Breakdown of academic impact, for papers by Joerg Steinmann Breakdown of academic impact, for papers by Rajesh Pandey Breakdown of academic impact, for papers by Hossam M. Ashour Breakdown of academic impact, for papers by Siddharth Sridhar Breakdown of academic impact, for papers by Leon Caly Breakdown of academic impact, for papers by Liping Wang Breakdown of academic impact, for papers by Amit Kumar Verma
Rankless by CCL
2026